[EN] CANNABINOID RECEPTOR LIGANDS<br/>[FR] LIGANDS DES RECEPTEURS CANNABINOIDES
申请人:SCHERING CORP
公开号:WO2006002133A1
公开(公告)日:2006-01-05
Compounds of Formula (I) and/or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions containing such compounds exhibit anti-inflammatory and immunomodulatory activity, and can be effective asCB2 receptor ligands in treating cancer and inflammatory, immunomodulatory or respiratory diseases or conditions.
Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands
作者:Ling Tong、B.B. Shankar、Lei Chen、Razia Rizvi、Joseph Kelly、Eric Gilbert、Chunli Huang、De-Yi Yang、Joseph A. Kozlowski、N.-Y. Shih、W. Gonsiorek、R. William Hipkin、Asra Malikzay、Charles A. Lunn、Daniel J. Lundell
DOI:10.1016/j.bmcl.2010.08.126
日期:2010.11
We report further expansion of the structure activity relationship (SAR) on the triaryl bis sulfone class of compounds (I), which are potent CB2 receptor ligands with excellent selectivity over the CB1 receptor. This study was extended to B ring changes, followed by simultaneous optimization of the A-, B-, and C-rings. Compound 42 has excellent CB2 potency, selectivity and rat exposure. (C) 2010 Elsevier Ltd. All rights reserved.